Three years in the past, I used to be working at a biotech firm main a drug discovery program targeted on metabolic illness. Excited about acquiring liver samples that might assist determine potential therapeutic targets, I realized {that a} tenured professor at a high 10 NIH establishment had greater than 2,000 samples of tissue from sufferers they’d accrued over greater than a decade of analysis. I reached out to evaluate whether or not we’d discover a strategy to presumably collaborate, utilizing their samples to assist speed up our program and offering new insights for samples the professor had but to judge.
The partnership by no means received off the bottom. However one aspect of the dialog caught. Once I requested the professor what their plans have been for the samples — did they hope to work with them after they secured further funding or share them with others? — they famous they’d no plan. In brief, they’d samples. Supposed to gather extra of them. And had no quick plans to do something with them.
That is frequent. These of us in analysis routinely retailer affected person samples — blood, fluids, tissue, scrapings, and different organic supplies — collected throughout scientific care. The Nationwide Bioethics Advisory Fee estimates there are greater than 280 million samples in the USA, with greater than 20 million added yearly.
Proceed to STAT+ to learn the total story…
